244 related articles for article (PubMed ID: 27859470)
21. Risk of Advanced Adenomas in Siblings of Individuals With Advanced Adenomas: A Cross-Sectional Study.
Ng SC; Lau JY; Chan FK; Suen BY; Tse YK; Hui AJ; Leung-Ki EL; Ching JY; Chan AW; Wong MC; Ng SS; To KF; Wu JC; Sung JJ
Gastroenterology; 2016 Mar; 150(3):608-16; quiz e16-7. PubMed ID: 26584600
[TBL] [Abstract][Full Text] [Related]
22. The Fatty Liver Index: A Simple and Accurate Predictor of Colorectal Adenoma in an Average-Risk Population.
Ze EY; Kim BJ; Jun DH; Kim JG; Kang H; Lee DY
Dis Colon Rectum; 2018 Jan; 61(1):36-42. PubMed ID: 29219920
[TBL] [Abstract][Full Text] [Related]
23. Nonalcoholic fatty liver disease and advanced fibrosis are associated with left ventricular diastolic dysfunction.
Chung GE; Lee JH; Lee H; Kim MK; Yim JY; Choi SY; Kim YJ; Yoon JH; Kim D
Atherosclerosis; 2018 May; 272():137-144. PubMed ID: 29604480
[TBL] [Abstract][Full Text] [Related]
24. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia.
Regula J; Rupinski M; Kraszewska E; Polkowski M; Pachlewski J; Orlowska J; Nowacki MP; Butruk E
N Engl J Med; 2006 Nov; 355(18):1863-72. PubMed ID: 17079760
[TBL] [Abstract][Full Text] [Related]
25. Clinical impact of non-alcoholic fatty liver disease on the occurrence of colorectal neoplasm: Propensity score matching analysis.
Yang YJ; Bang CS; Shin SP; Baik GH
PLoS One; 2017; 12(8):e0182014. PubMed ID: 28777831
[TBL] [Abstract][Full Text] [Related]
26. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals.
Lieberman DA; Prindiville S; Weiss DG; Willett W;
JAMA; 2003 Dec; 290(22):2959-67. PubMed ID: 14665657
[TBL] [Abstract][Full Text] [Related]
28. A greater proportion of liver transplant candidates have colorectal neoplasia than in the healthy screening population.
Jeschek P; Ferlitsch A; Salzl P; Heinze G; Györi G; Reinhart K; Waldmann E; Britto-Arias M; Trauner M; Ferlitsch M
Clin Gastroenterol Hepatol; 2015 May; 13(5):956-62. PubMed ID: 25151257
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of a colonoscopic screening programme in first-degree relatives of patients with colorectal cancer.
Puente Gutiérrez JJ; Marín Moreno MA; Domínguez Jiménez JL; Bernal Blanco E; Díaz Iglesias JM
Colorectal Dis; 2011 Jun; 13(6):e145-53. PubMed ID: 21564467
[TBL] [Abstract][Full Text] [Related]
30. Moderate to severe, but not mild, nonalcoholic fatty liver disease associated with increased risk of gallstone disease.
Lee YC; Wu JS; Yang YC; Chang CS; Lu FH; Chang CJ
Scand J Gastroenterol; 2014 Aug; 49(8):1001-6. PubMed ID: 24989169
[TBL] [Abstract][Full Text] [Related]
31. Colorectal cancer risk factors in the detection of advanced adenoma and colorectal cancer.
Stegeman I; de Wijkerslooth TR; Stoop EM; van Leerdam ME; Dekker E; van Ballegooijen M; Kuipers EJ; Fockens P; Kraaijenhagen RA; Bossuyt PM
Cancer Epidemiol; 2013 Jun; 37(3):278-83. PubMed ID: 23491770
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for advanced colorectal adenomas: a pooled analysis.
Terry MB; Neugut AI; Bostick RM; Sandler RS; Haile RW; Jacobson JS; Fenoglio-Preiser CM; Potter JD
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):622-9. PubMed ID: 12101109
[TBL] [Abstract][Full Text] [Related]
33. Impact of family history of colorectal cancer on age-specific prevalence of colorectal neoplasia.
Park CH; Kim NH; Park JH; Park DI; Sohn CI; Jung YS
J Gastroenterol Hepatol; 2019 Mar; 34(3):537-543. PubMed ID: 30462856
[TBL] [Abstract][Full Text] [Related]
34. Association of nonalcoholic fatty liver disease with colorectal adenomatous polyps and non-adenomatous polyps: a cross-sectional study.
Yang Y; Teng Y; Shi J; Xu J; Bao J; Zhang X; Wang Q
Eur J Gastroenterol Hepatol; 2023 Dec; 35(12):1389-1393. PubMed ID: 37642651
[TBL] [Abstract][Full Text] [Related]
35. The Risk of Colorectal Adenoma in Nonalcoholic or Metabolic-Associated Fatty Liver Disease.
Seo JY; Bae JH; Kwak MS; Yang JI; Chung SJ; Yim JY; Lim SH; Chung GE
Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680518
[TBL] [Abstract][Full Text] [Related]
36. Association between severe hepatic steatosis examined by Fibroscan and the risk of high-risk colorectal neoplasia.
Kim KW; Kang HW; Yoo H; Jun Y; Lee HJ; Im JP; Kim JW; Kim JS; Koh SJ; Jung YJ
PLoS One; 2022; 17(12):e0279242. PubMed ID: 36548355
[TBL] [Abstract][Full Text] [Related]
37. Five-year colon surveillance after screening colonoscopy.
Lieberman DA; Weiss DG; Harford WV; Ahnen DJ; Provenzale D; Sontag SJ; Schnell TG; Chejfec G; Campbell DR; Kidao J; Bond JH; Nelson DB; Triadafilopoulos G; Ramirez FC; Collins JF; Johnston TK; McQuaid KR; Garewal H; Sampliner RE; Esquivel R; Robertson D
Gastroenterology; 2007 Oct; 133(4):1077-85. PubMed ID: 17698067
[TBL] [Abstract][Full Text] [Related]
38. Increased risk of colorectal neoplasia among family members of patients with colorectal cancer: a population-based study in Utah.
Samadder NJ; Curtin K; Tuohy TM; Rowe KG; Mineau GP; Smith KR; Pimentel R; Wong J; Boucher K; Burt RW
Gastroenterology; 2014 Oct; 147(4):814-821.e5; quiz e15-6. PubMed ID: 25042087
[TBL] [Abstract][Full Text] [Related]
39. Colonoscopic screening of average-risk women for colorectal neoplasia.
Schoenfeld P; Cash B; Flood A; Dobhan R; Eastone J; Coyle W; Kikendall JW; Kim HM; Weiss DG; Emory T; Schatzkin A; Lieberman D;
N Engl J Med; 2005 May; 352(20):2061-8. PubMed ID: 15901859
[TBL] [Abstract][Full Text] [Related]
40. Assessing individual risk for high-risk colorectal adenoma at first-time screening colonoscopy.
Cao Y; Rosner BA; Ma J; Tamimi RM; Chan AT; Fuchs CS; Wu K; Giovannucci EL
Int J Cancer; 2015 Oct; 137(7):1719-1728. PubMed ID: 25820865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
